1.
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics
2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185
countries. CA Cancer J Clin. 68(6):394-424;2018.
2.
Uedo N, Takeuchi Y, Ishihara R. Endoscopic management of early gastric cancer:
endoscopic mucosal resection or endoscopic submucosal dissection: data from a Japanese
high-volume center and literature review. Ann Gastroenterol.25(4):281-290; 2012.
3.
Draganov PV, Wang AY, Othman MO, Fukami N. AGA Institute Clinical Practice
Update: Endoscopic Submucosal Dissection in the United States. Clin Gastroenterol
Hepatol. 17(1):16-25.e11;2019.
4.
Sakitani K, Nishizawa T, Arita M, Yoshida S, Kataoka Y, Ohki D, Yamashita H, Isomura
Y, Toyoshima A, Watanabe H, Iizuka T, Saito Y, Fujisaki J, Yahagi N, Koike K, Toyoshima
O. Early detection of gastric cancer after Helicobacter pylori eradication due to endoscopic
surveillance. Helicobacter. 23(4):e12503;2018.
5.
Nishizawa T, Suzuki H, Arano T, Yoshida S, Yamashita H, Hata K, Kanai T, Yahagi N,
Toyoshima O. Characteristics of gastric cancer detected within 1 year after successful
eradication of Helicobacter pylori. J Clin Biochem Nutr. 59(3):226-230;2016.
6.
Malfertheiner P, Megraud F, O'Morain CA, Gisbert JP, Kuipers EJ, Axon AT, Bazzoli F,
Gasbarrini A, Atherton J, Graham DY, Hunt R, Moayyedi P, Rokkas T, Rugge M, Selgrad
M, Suerbaum S, Sugano K, El-Omar EM. Management of Helicobacter pylori infectionthe Maastricht V/Florence Consensus Report. Gut. 66(1):6-30;2017.
7.
Banks M, Graham D, Jansen M, Gotoda T, Coda S, di Pietro M, Uedo N, Bhandari P,
Pritchard DM, Kuipers EJ, Rodriguez-Justo M, Novelli MR, Ragunath K, Shepherd N,
Dinis-Ribeiro M. British Society of Gastroenterology guidelines on the diagnosis and
management of patients at risk of gastric adenocarcinoma. Gut. 68(9):1545-1575;2019.
8.
Pimentel-Nunes P, Libânio D, Marcos-Pinto R, Areia M, Leja M, Esposito G, Garrido M,
Kikuste I, Megraud F, Matysiak-Budnik T, Annibale B, Dumonceau J-M, Barros R, Fléjou
J-F, Carneiro F, van Hooft JE, Kuipers EJ, Dinis-Ribeiro M. Management of epithelial
precancerous conditions and lesions in the stomach (MAPS II): European Society of
Gastrointestinal Endoscopy (ESGE), European Helicobacter and Microbiota Study Group
(EHMSG), European Society of Pathology (ESP), and Sociedade Portuguesa de
Endoscopia Digestiva (SPED) guideline update 2019. Endoscopy. 51(04):365-388;2019.
9.
Lichtenstein P, Holm NV, Verkasalo PK, Iliadou A, Kaprio J, Koskenvuo M, Pukkala E,
Skytthe A, Hemminki K. Environmental and heritable factors in the causation of cancer-analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med.
88
343(2):78-85;2000.
10.
Sakamoto H, Yoshimura K, Saeki N, Katai H, Shimoda T, Matsuno Y, Saito D, Sugimura
H, Tanioka F, Kato S, Matsukura N, Matsuda N, Nakamura T, Hyodo I, Nishina T, Yasui
W, Hirose H, Hayashi M, Toshiro E, Ohnami S, Sekine A, Sato Y, Totsuka H, Ando M,
Takemura R, Takahashi Y, Ohdaira M, Aoki K, Honmyo I, Chiku S, Aoyagi K, Sasaki H,
Ohnami S, Yanagihara K, Yoon KA, Kook MC, Lee YS, Park SR, Kim CG, Choi IJ, Yoshida
T, Nakamura Y, Hirohashi S. Genetic variation in PSCA is associated with susceptibility
to diffuse-type gastric cancer. Nat Genet. 40(6):730-740;2008.
11.
Tanikawa C, Urabe Y, Matsuo K, Kubo M, Takahashi A, Ito H, Tajima K, Kamatani N,
Nakamura Y, Matsuda K. A genome-wide association study identifies two susceptibility
loci for duodenal ulcer in the Japanese population. Nat Genet. 44(4):430-434, S431432;2012.
12.
Han MA, Oh MG, Choi IJ, Park SR, Ryu KW, Nam BH, Cho SJ, Kim CG, Lee JH, Kim
YW. Association of family history with cancer recurrence and survival in patients with
gastric cancer. J Clin Oncol. 30(7):701-708;2012.
13.
Nishizawa T, Suzuki H, Sakitani K, Yamashita H, Yoshida S, Hata K, Kanazawa T,
Fujiwara N, Kanai T, Yahagi N, Toyoshima O. Family history is an independent risk factor
for the progression of gastric atrophy among patients with Helicobacter pylori infection.
United European Gastroenterol J. 5(1):32-36; 2016.
14.
Toyoshima O, Tanikawa C, Yamamoto R, Watanabe H, Yamashita H, Sakitani K, Yoshida
S, Kubo M, Matsuo K, Ito H, Koike K, Seto Y, Matsuda K. Decrease in PSCA expression
caused by Helicobacter pylori infection may promote progression to severe gastritis.
Oncotarget. 9(3):3936-3945;2018.
15.
Choi IJ, Kim CG, Lee JY, Kim Y-I, Kook M-C, Park B, Joo J. Family History of Gastric
Cancer and Helicobacter pylori Treatment. N Engl J Med. 382(5):427-436;2020.
16.
IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Schistosomes,
liver flukes and Helicobacter pylori. IARC Monogr Eval Carcinog Risks Hum. 61:1241;1994.
17.
Warren JR, Marshall B. Unidentified curved bacilli on gastric epithelium in active chronic
gastritis. Lancet. 1(8336):1273-1275;1983.
18.
Hooi JKY, Lai WY, Ng WK, Suen MMY, Underwood FE, Tanyingoh D, Malfertheiner P,
Graham DY, Wong VWS, Wu JCY, Chan FKL, Sung JJY, Kaplan GG, Ng SC. Global
Prevalence of Helicobacter pylori Infection: Systematic Review and Meta-Analysis.
Gastroenterology. 153(2):420-429;2017.
19.
Plummer M, Franceschi S, Vignat J, Forman D, de Martel C. Global burden of gastric
cancer attributable to Helicobacter pylori. Int J Cancer. 136(2):487-490;2015.
89
20.
Yamaoka Y. Mechanisms of disease: Helicobacter pylori virulence factors. Nat Rev
Gastroenterol Hepatol. 7(11):629-641;2010.
21.
Hatakeyama M. Helicobacter pylori CagA and gastric cancer: a paradigm for hit-and-run
carcinogenesis. Cell Host Microbe. 15(3):306-316;2014.
22.
Talebi Bezmin Abadi A, Perez-Perez G. Role of dupA in virulence of Helicobacter pylori.
World J Gastroenterol. 22(46):10118-10123;2016.
23.
Imkamp F, Lauener FN, Pohl D, Lehours P, Vale FF, Jehanne Q, Zbinden R, Keller PM,
Wagner K. Rapid Characterization of Virulence Determinants in Helicobacter pylori
Isolated from Non-Atrophic Gastritis Patients by Next-Generation Sequencing. J Clin
Med. 8(7):1030;2019.
24.
Fukase K, Kato M, Kikuchi S, Inoue K, Uemura N, Okamoto S, Terao S, Amagai K,
Hayashi S, Asaka M, Japan Gast Study G. Effect of eradication of Helicobacter pylori on
incidence of metachronous gastric carcinoma after endoscopic resection of early gastric
cancer: an open-label, randomised controlled trial. Lancet. 372(9636):392-397;2008.
25.
Ma JL, Zhang L, Brown LM, Li JY, Shen L, Pan KF, Liu WD, Hu Y, Han ZX, CrystalMansour S, Pee D, Blot WJ, Fraumeni JF, Jr., You WC, Gail MH. Fifteen-year effects of
Helicobacter pylori, garlic, and vitamin treatments on gastric cancer incidence and
mortality. J Natl Cancer Inst. 104(6):488-492;2012.
26.
Lee Y-C, Chiang T-H, Chou C-K, Tu Y-K, Liao W-C, Wu M-S, Graham DY. Association
Between Helicobacter pylori Eradication and Gastric Cancer Incidence: A Systematic
Review and Meta-analysis. Gastroenterology. 150(5):1113-1124.e1115;2016.
27.
Ford AC, Yuan Y, Moayyedi P. Helicobacter pylori eradication therapy to prevent gastric
cancer: systematic review and meta-analysis. Gut. 2020-320839;2020.
28.
Nishizawa T, Suzuki H, Fujimoto A, Kinoshita H, Yoshida S, Isomura Y, Toyoshima A,
Kanai T, Yahagi N, Toyoshima O. Effects of patient age and choice of antisecretory agent
on success of eradication therapy for Helicobacter pylori infection. J Clin Biochem Nutr.
60(3):208-210;2017.
29.
Watanabe K, Nagata N, Nakashima R, Furuhata E, Shimbo T, Kobayakawa M, Sakurai T,
Imbe K, Niikura R, Yokoi C, Akiyama J, Uemura N. Predictive findings for Helicobacter
pylori-uninfected, -infected and -eradicated gastric mucosa: validation study. World J
Gastroenterol. 19(27):4374-4379;2013.
30.
Kato T, Yagi N, Kamada T, Shimbo T, Watanabe H, Ida K. Diagnosis of Helicobacter
pylori infection in gastric mucosa by endoscopic features: A multicenter prospective study.
Dig Endosc. 25(5):508-518;2013.
31.
Song H, Ekheden IG, Zheng Z, Ericsson J, Nyrén O, Ye W. Incidence of gastric cancer
among patients with gastric precancerous lesions: observational cohort study in a low risk
90
Western population. BMJ. 351:h3867;2015.
32.
Mao T, Wang Y, Yin F, Zhao Q, Yang L, Ding X, Tian Z. Association of Endoscopic
Features of Gastric Mucosa with Helicobacter pylori Infection in Chinese Patients.
Gastroenterol Res Pract. 2016:6539639;2016.
33.
Yoshii S, Mabe K, Watano K, Ohno M, Matsumoto M, Ono S, Kudo T, Nojima M, Kato
M, Sakamoto N. Validity of endoscopic features for the diagnosis of Helicobacter pylori
infection status based on the Kyoto classification of gastritis. Dig Endosc. 32(1):7483;2019.
34.
Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M,
Taniyama K, Sasaki N, Schlemper RJ. Helicobacter pylori infection and the development
of gastric cancer. N Engl J Med. 345(11):784-789;2001.
35.
Take S, Mizuno M, Ishiki K, Hamada F, Yoshida T, Yokota K, Okada H, Yamamoto K.
Seventeen-year effects of eradicating Helicobacter pylori on the prevention of gastric
cancer in patients with peptic ulcer; a prospective cohort study. J Gastroenterol.
50(6):638-644;2015.
36.
Toyoshima O, Yamaji Y, Yoshida S, Matsumoto S, Yamashita H, Kanazawa T, Hata K.
Endoscopic gastric atrophy is strongly associated with gastric cancer development after
Helicobacter pylori eradication. Surg Endosc. 31(5)2140-2148;2017.
37.
Kaji K, Hashiba A, Uotani C, Yamaguchi Y, Ueno T, Ohno K, Takabatake I, Wakabayashi
T, Doyama H, Ninomiya I, Kiriyama M, Ohyama S, Yoneshima M, Koyama N, Takeda Y,
Yasuda K. Grading of Atrophic Gastritis is Useful for Risk Stratification in Endoscopic
Screening for Gastric Cancer. Am J Gastroenterol. 114(1):71-79;2019.
38.
Toyoshima O Nishizawa T, Koike K. Endoscopic Kyoto classification of Helicobacter
pylori infection and gastric cancer risk diagnosis. World J Gastroenterol. 26(5):466477;2020.
39.
Toyoshima O, Nishizawa T, Sakitani K, Yamakawa T, Watanabe H, Yoshida S, Nakai Y,
Hata K, Ebinuma H, Suzuki H, Koike K. Nodularity-like appearance in the cardia: novel
endoscopic findings for Helicobacter pylori infection. Endosc Int Open. 8(6):E770E774;2020.
40.
Toyoshima O, Yoshida S, Nishizawa T, Yamakawa T, Sakitani K, Hata K, Takahashi Y,
Fujishiro M, Watanabe H, Koike K. CF290 for pancolonic chromoendoscopy improved
sessile serrated polyp detection and procedure time: a propensity score-matching study.
Endosc Int Open. 7(8):E987-E993;2019.
41.
Toyoshima O, Hata K, Yoshida S, Arita M. New-generation chromoendoscopy may
increase confidence in the DISCARD2 study. Gut. 67(9):1742-1743;2018.
42.
Toyoshima O Nishizawa T, Yoshida S, Sekiba K, Kataoka Y, Hata K, Watanabe H, Tsuji
91
Y, Koike K. Expert endoscopists with high adenoma detection rates frequently detect
diminutive adenomas in proximal colon. Endosc Int Open. 8(6):E775-E782;2020.
43.
Toyoshima O, Nishizawa T, Sakitani K, Yamakawa T, Yoshida S, Fukagawa K, Hata K,
Ishihara S, Suzuki H. Colonoscopy using back brace support belt: A randomized,
prospective trial. JGH Open. 4(3):441-445;2019.
44.
Nishizawa T, Suzuki H, Arita M, Kataoka Y, Fukagawa K, Ohki D, Hata K, Uraoka T,
Kanai T, Yahagi N, Toyoshima O. Pethidine dose and female sex as risk factors for nausea
after esophagogastroduodenoscopy. J Clin Biochem Nutr. 63(3):230-232;2018.
45.
Nishizawa T, Sakitani K, Suzuki H, Takeuchi M, Takahashi Y, Takeuchi K, Yamakawa T,
Yoshida S, Hata K, Ebinuma H, Koike K, Toyoshima O. Adverse events associated with
bidirectional endoscopy with midazolam and pethidine. J Clin Biochem Nutr. 66(1):7881;2020.
46.
Nishizawa T, Sakitani K, Suzuki H, Yamakawa T, Takahashi Y, Yoshida S, Nakai Y, Hata
K, Ebinuma H, Koike K, Toyoshima O. Small-caliber endoscopes are more fragile than
conventional endoscopes. Endosc Int Open. 7(12):E1729-E1732;2019.
47.
Kato M. Endoscopic Findings of H. pylori Infection. Helicobacter pylori. 157-167;2016.
48.
Haruma K, Kato M, Inoue K, Murakami K, Kamada T, eds. Kyoto Classification of
Gastritis. 1st Edition ed. Tokyo Japan: Nihon Medical Center; 2017.
49.
Sugimoto M, Ban H, Ichikawa H, Sahara S, Otsuka T, Inatomi O, Bamba S, Furuta T,
Andoh A. Efficacy of the Kyoto Classification of Gastritis in Identifying Patients at High
Risk for Gastric Cancer. Intern Med. 56(6):579-586;2017.
50.
Shichijo S, Hirata Y, Niikura R, Hayakawa Y, Yamada A, Koike K. Association between
gastric cancer and the Kyoto Classification of Gastritis. J Gastroenterol Hepatol.
32(9):1581-1586;2017.
51.
Sakitani K, Nishizawa T, Toyoshima A, Yoshida S, Matsuno T, Yamada T, Irokawa M,
Takahashi Y, Nakai Y, Toyoshima O, Koike K. Kyoto classification in patients who
developed multiple gastric carcinomas after Helicobacter pylori eradication. World J
Gastrointest Endosc. 12(9):276-284;2020.
52.
Toyoshima O, Nishizawa T, Yoshida S, Sakaguchi Y, Nakai Y, Watanabe H, Suzuki H,
Tanikawa C, Matsuda K, Koike K. Endoscopy-based Kyoto classification score of gastritis
related to pathological topography of neutrophil activity. World J Gastroenterol.
26(34):5146-5155;2020.
53.
Toyoshima O, Nishizawa T, Sakitani K, Yamakawa T, Takahashi Y, Kinoshita K, Torii A,
Yamada A, Suzuki H, Koike K. Helicobacter pylori eradication improved the Kyoto
classification score on endoscopy. JGH Open. 4(5):909-914;2020.
54.
Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis. The
92
updated Sydney System. International Workshop on the Histopathology of Gastritis,
Houston 1994. Am J Surg Pathol. 20(10):1161-1181;1996.
55.
Kimura K, Takemoto T. An endoscopic recognition of the atrophic border and its
significance in chronic gastritis. Endoscopy. 3:87-97;1969.
56.
Naylor GM, Gotoda T, Dixon M, Shimoda T, Gatta L, Owen R, Tompkins D, Axon A.
Why does Japan have a high incidence of gastric cancer? Comparison of gastritis between
UK and Japanese patients. Gut. 55(11):1545-1552;2006.
57.
Quach DT, Le HM, Nguyen OT, Nguyen TS, Uemura N. The severity of endoscopic
gastric atrophy could help to predict Operative Link on Gastritis Assessment gastritis
stage. J Gastroenterol Hepatol. 26(2):281-285;2011.
58.
Quach DT, Le HM, Hiyama T, Nguyen OT, Nguyen TS, Uemura N. Relationship
between endoscopic and histologic gastric atrophy and intestinal metaplasia. Helicobacter.
18(2):151-157;2013.
59.
Kono S, Gotoda T, Yoshida S, Oda I, Kondo H, Gatta L, Naylor G, Dixon M, Moriyasu F,
Axon A. Can endoscopic atrophy predict histological atrophy? Historical study in United
Kingdom and Japan. World J Gastroenterol. 21(46):13113-13123;2015.
60.
Correa P. Human gastric carcinogenesis: a multistep and multifactorial process--First
American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer
Res. 52(24):6735-6740;1992.
61.
Fukuta N, Ida K, Kato T, Uedo N, Ando T, Watanabe H, Shimbo T. Endoscopic diagnosis
of gastric intestinal metaplasia: A prospective multicenter study. Digestive Endoscopy.
25(5):526-534;2013.
62.
Pimentel-Nunes P, Libânio D, Lage J, Abrantes D, Coimbra M, Esposito G, Hormozdi D,
Pepper M, Drasovean S, White JR, Dobru D, Buxbaum J, Ragunath K, Annibale B, DinisRibeiro M. A multicenter prospective study of the real-time use of narrow-band imaging
in the diagnosis of premalignant gastric conditions and lesions. Endoscopy. 48(8):723730;2016.
63.
Chiu PWY, Uedo N, Singh R, Gotoda T, Ng EKW, Yao K, Ang TL, Ho SH, Kikuchi D,
Yao F, Pittayanon R, Goda K, Lau JYW, Tajiri H, Inoue H. An Asian consensus on
standards of diagnostic upper endoscopy for neoplasia. Gut. 68(2):186-197;2019.
64.
Esposito G, Pimentel-Nunes P, Angeletti S, Castro R, Libânio D, Galli G, Lahner E, Di
Giulio E, Annibale B, Dinis-Ribeiro M. Endoscopic grading of gastric intestinal metaplasia
(EGGIM): a multicenter validation study. Endoscopy. 51(6):515-521;2019.
65.
Takeda T, Asaoka D, Nojiri S, Nishiyama M, Ikeda A, Yatagai N, Ishizuka K, Hiromoto T,
Okubo S, Suzuki M, Nakajima A, Nakatsu Y, Komori H, Akazawa Y, Nakagawa Y, Izumi
K, Matsumoto K, Ueyama H, Sasaki H, Shimada Y, Matsumoto K, Osada T, Hojo M, Kato
93
M, Nagahara A. Linked Color Imaging and the Kyoto Classification of Gastritis:
Evaluation of Visibility and Inter-Rater Reliability. Digestion. 101(5):598-607;2020.
66.
Dohi O, Majima A, Naito Y, Yoshida T, Ishida T, Azuma Y, Kitae H, Matsumura S,
Mizuno N, Yoshida N, Kamada K, Itoh Y. Can image-enhanced endoscopy improve the
diagnosis of Kyoto classification of gastritis in the clinical setting? Dig Endosc. 32(2):191203;2020.
67.
Uedo N, Ishihara R, Iishi H, Yamamoto S, Yamamoto S, Yamada T, Imanaka K, Takeuchi
Y, Higashino K, Ishiguro S, Tatsuta M. A new method of diagnosing gastric intestinal
metaplasia: narrow-band imaging with magnifying endoscopy. Endoscopy. 38(8):819824;2006.
68.
Kanemitsu T, Yao K, Nagahama T, Imamura K, Fujiwara S, Ueki T, Chuman K, Tanabe
H, Atsuko O, Iwashita A, Shimokawa T, Uchita K, Kanesaka T. Extending magnifying NBI
diagnosis of intestinal metaplasia in the stomach: the white opaque substance marker.
Endoscopy. 49(6):529-535;2017.
69.
Achyut BR, Moorchung N, Srivastava AN, Gupta NK, Mittal B. Risk of lymphoid follicle
development in patients with chronic antral gastritis: role of endoscopic features,
histopathological parameters, CagA status and interleukin-1 gene polymorphisms.
Inflamm Res. 57(2):51-56;2008.
70.
Miyamoto M, Haruma K, Yoshihara M, Hiyama T, Sumioka M, Nishisaka T, Tanaka S,
Chayama K. Nodular gastritis in adults is caused by Helicobacter pylori infection. Dig Dis
Sci. 48(5):968-975;2003.
71.
Chen MJ, Wang TE, Chang WH, Liao TC, Lin CC, Shih SC. Nodular gastritis: an
endoscopic indicator of Helicobacter Pylori infection. Dig Dis Sci. 52(10):26622666;2007.
72.
Nomura S, Terao S, Adachi K, Kato T, Ida K, Watanabe H, Shimbo T. Endoscopic
diagnosis of gastric mucosal activity and inflammation. Dig Endosc. 25(2):136-146;2013.
73.
Nishikawa I, Kato J, Terasoma S, Matsutani H, Tamaki H, Tamaki T, Kuwashima F,
Nakata H, Tomeki T, Matsunaka H, Ibata Y, Yamashita Y, Maekita T, Higashi K, Ichinose
M. Nodular gastritis in association with gastric cancer development before and after
Helicobacter pylori eradication. JGH Open. 2(3):80-86;2018.
74.
Uchiyama K, Ida K, Okuda J, Asai Y, Ohyama Y, Kuroda M, Matsumoto N, Takami T,
Ogawa T, Takaori K. Correlations of hemoglobin index (IHb) of gastric mucosa with
Helicobacter pylori (H. pylori) infection and inflammation of gastric mucosa. Scand J
Gastroenterol. 39(11):1054-1060;2004.
75.
Dinis-Ribeiro M, Areia M, de Vries AC, Marcos-Pinto R, Monteiro-Soares M, O'Connor
A, Pereira C, Pimentel-Nunes P, Correia R, Ensari A, Dumonceau JM, Machado JC,
94
Macedo G, Malfertheiner P, Matysiak-Budnik T, Megraud F, Miki K, O'Morain C, Peek
RM, Ponchon T, Ristimaki A, Rembacken B, Carneiro F, Kuipers EJ. Management of
precancerous conditions and lesions in the stomach (MAPS): guideline from the European
Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group
(EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de
Endoscopia Digestiva (SPED). Endoscopy. 44(1):74-94;2012.
76.
Parente F, Sainaghi M, Sangaletti O, Imbesi V, Maconi G, Anderloni A, Bianchi Porro G.
Different effects of short-term omeprazole, lansoprazole or pantoprazole on the accuracy
of the 13C-urea breath test. Aliment Pharmacol Ther. 16(3):553-557;2002.
77.
Tonkic A, Tonkic M, Lehours P, Megraud F. Epidemiology and diagnosis of Helicobacter
pylori infection. Helicobacter. Suppl 1:1-8;2012.
78.
Burucoa C, Delchier JC, Courillon-Mallet A, de Korwin JD, Megraud F, Zerbib F,
Raymond J, Fauchere JL. Comparative evaluation of 29 commercial Helicobacter pylori
serological kits. Helicobacter. 18(3):169-179;2013.
79.
栄研化学株式会社. ヘリコバクターピロリ抗体キット E プレート‘栄研’H.ピロリ抗体 II.
第 2 版. 2015.( https://www.info.pmda.go.jp/tgo/pack/22200AMX00935000_A_01_02/)
80.
Tatemichi M, Sasazuki S, Inoue M, Tsugane S. Clinical significance of IgG antibody titer
against Helicobacter pylori. Helicobacter. 14(3):231-236;2009.
81.
Matsuo T, Ito M, Takata S, Tanaka S, Yoshihara M, Chayama K. Low prevalence of
Helicobacter pylori-negative gastric cancer among Japanese. Helicobacter. 16(6):415419;2011.
82.
Lauren P. The Two Histological Main Types of Gastric Carcinoma: Diffuse and So-Called
Intestinal-Type Carcinoma. An Attempt at a Histo-Clinical Classification. Acta Pathol
Microbiol Scand. 64:31-49;1965.
83.
Yamaji Y, Mitsushima T, Ikuma H, Okamoto M, Yoshida H, Kawabe T, Shiratori Y, Saito
K, Yokouchi K, Omata M. Weak response of helicobacter pylori antibody is high risk for
gastric cancer: a cross-sectional study of 10,234 endoscoped Japanese. Scand J
Gastroenterol. 37(2):148-153;2002.
84.
Kishikawa H, Kimura K, Takarabe S, Kaida S, Nishida J. Helicobacter pylori Antibody
Titer and Gastric Cancer Screening. Dis Markers. 2015:156719;2015.
85.
Kiso M, Yoshihara M, Ito M, Inoue K, Kato K, Nakajima S, Mabe K, Kobayashi M, Uemura
N, Yada T, Oka M, Kawai T, Boda T, Kotachi T, Masuda K, Tanaka S, Chayama K.
Characteristics of gastric cancer in negative test of serum anti-Helicobacter pylori
antibody and pepsinogen test: a multicenter study. Gastric Cancer. 20(5):764-771;2017.
86.
Yamaji Y, Mitsushima T, Ikuma H, Okamoto M, Yoshida H, Kawabe T, Shiratori Y, Saito
K, Yokouchi K, Omata M. Inverse background of Helicobacter pylori antibody and
95
pepsinogen in reflux oesophagitis compared with gastric cancer: analysis of 5732 Japanese
subjects. Gut. 49(3):335-340;2001.
87.
Ohata H, Kitauchi S, Yoshimura N, Mugitani K, Iwane M, Nakamura H, Yoshikawa A,
Yanaoka K, Arii K, Tamai H, Shimizu Y, Takeshita T, Mohara O, Ichinose M. Progression
of chronic atrophic gastritis associated with Helicobacter pylori infection increases risk of
gastric cancer. Int J Cancer. 109(1):138-143;2004.
88.
Sugano K, Tack J, Kuipers EJ, Graham DY, El-Omar EM, Miura S, Haruma K, Asaka M,
Uemura N, Malfertheiner P. Kyoto global consensus report on Helicobacter pylori gastritis.
Gut. 64(9):1353-1367;2015.
89.
Toyoshima O, Nishizawa T, Sakitani K, Yamakawa T, Takahashi Y, Yamamichi N, Hata
K, Seto Y, Koike K, Watanabe H, Suzuki H. Serum anti-Helicobacter pylori antibody titer
and its association with gastric nodularity, atrophy, and age: A cross-sectional study.
World J Gastroenterol. 24(35):4061-4068;2018.
90.
Toyoshima O, Nishizawa T, Arita M, Kataoka Y, Sakitani K, Yoshida S, Yamashita H, Hata
K, Watanabe H, Suzuki H. Helicobacter pylori infection in subjects negative for high titer
serum antibody. World J Gastroenterol. 24(13):1419-1428;2018.
91.
Perkins NJ, Schisterman EF. The inconsistency of "optimal" cutpoints obtained using two
criteria based on the receiver operating characteristic curve. Am J Epidemiol. 163(7):670675;2006.
92.
Laine L, Cohen H, Sloane R, Marin-Sorensen M, Weinstein WM. Interobserver
agreement and predictive value of endoscopic findings for H. pylori and gastritis in normal
volunteers. Gastrointest Endosc. 42(5):420-423;1995.
93.
Yagi K, Nakamura A, Sekine A. Characteristic endoscopic and magnified endoscopic
findings in the normal stomach without Helicobacter pylori infection. J Gastroenterol
Hepatol. 17(1):39-45;2002.
94.
Garces-Duran R, Garcia-Rodriguez A, Cordova H, Cuatrecasas M, Gines A, GonzalezSuarez B, Araujo I, Llach J, Fernandez-Esparrach G. Association between a regular
arrangement of collecting venules and absence of Helicobacter pylori infection in a
European population. Gastrointest Endosc. 90(3):461-466;2019.
95.
Masuyama H, Yoshitake N, Sasai T, Nakamura T, Masuyama A, Zuiki T, Kurashina K,
Mieda M, Sunada K, Yamamoto H, Togashi K, Terano A, Hiraishi H. Relationship
between the degree of endoscopic atrophy of the gastric mucosa and carcinogenic risk.
Digestion. 91(1):30-36;2015.
96.
Nishizawa T, Sakitani K, Suzuki H, Yamakawa T, Takahashi Y, Yamamichi N, Watanabe
H, Seto Y, Koike K, Toyoshima O. A combination of serum anti-Helicobacter pylori
antibody titer and Kyoto classification score could provide a more accurate diagnosis of H
96
pylori. United European Gastroenterol J. 7(3):343-348;2019.
97.
Rubicz R, Leach CT, Kraig E, Dhurandhar NV, Duggirala R, Blangero J, Yolken R, Göring
HHH. Genetic Factors Influence Serological Measures of Common Infections. Hum
Hered. 72(2):133-141;2011.
98.
Kreuning J, Lindeman J, Biemond I, Lamers CB. Relation between IgG and IgA antibody
titres against Helicobacter pylori in serum and severity of gastritis in asymptomatic
subjects. J Clin Pathol. 47(3):227-231;1994.
99.
Zagari RM, Pozzato P, Martuzzi C, Fuccio L, Martinelli G, Roda E, Bazzoli F. 13C-urea
breath test to assess Helicobacter pylori bacterial load. Helicobacter. 10(6):615-619;2005.
100.
Tatemichi M, Sasazuki S, Inoue M, Tsugane S. Different etiological role of Helicobacter
pylori (Hp) infection in carcinogenesis between differentiated and undifferentiated
gastric cancers: a nested case-control study using IgG titer against Hp surface antigen.
Acta Oncol. 47(3):360-365;2008.
101.
Kamada T, Tanaka A, Yamanaka Y, Manabe N, Kusunoki H, Miyamoto M, Tanaka S, Hata
J, Chayama K, Haruma K. Nodular gastritis with Helicobacter pylori infection is strongly
associated with diffuse-type gastric cancer in young patients. Dig Endosc. 19(4):180184;2007.
102.
Yoshida T, Kato J, Inoue I, Yoshimura N, Deguchi H, Mukoubayashi C, Oka M, Watanabe
M, Enomoto S, Niwa T, Maekita T, Iguchi M, Tamai H, Utsunomiya H, Yamamichi N,
Fujishiro M, Iwane M, Takeshita T, Ushijima T, Ichinose M. Cancer development based
on chronic active gastritis and resulting gastric atrophy as assessed by serum levels of
pepsinogen and Helicobacter pylori antibody titer. Int J Cancer. 134(6):1445-1457;2014.
103.
Redéen S, Petersson F, Kechagias S, Mårdh E, Borch K. Natural history of chronic gastritis
in a population-based cohort. Scand J Gastroenterol. 45(5):540-549;2010.
104.
Marchildon P, Balaban DH, Sue M, Charles C, Doobay R, Passaretti N, Peacock J,
Marshall BJ, Peura DA. Usefulness of serological IgG antibody determinations for
confirming eradication of Helicobacter pylori infection. Am J Gastroenterol. 94(8):21052108;1999.
105.
Correa P, Shiao YH. Phenotypic and genotypic events in gastric carcinogenesis. Cancer
Res. 54(7 Suppl):1941s-1943s;1994.
106.
Craanen ME, Dekker W, Blok P, Ferwerda J, Tytgat GN. Intestinal metaplasia and
Helicobacter pylori: an endoscopic bioptic study of the gastric antrum. Gut. 33(1):1620;1992.
107.
Wang CC, Wu MS, Wang HH, Wang HP, Lee WC, Shun CT, Lin JT. Helicobacter pylori
infection and age on the development of intestinal metaplasia--a multiple logistic
regression analysis. Hepatogastroenterology. 45(24):2234-2237;1998.
97
108.
Coati I, Fassan M, Farinati F, Graham DY, Genta RM, Rugge M. Autoimmune gastritis:
Pathologist's viewpoint. World J Gastroenterol. 21(42):12179-12189;2015.
109.
Kishikawa H, Ojiro K, Nakamura K, Katayama T, Arahata K, Takarabe S, Miura S, Kanai
T, Nishida J. Previous Helicobacter pylori infection-induced atrophic gastritis: A distinct
disease entity in an understudied population without a history of eradication. Helicobacter.
25(1):e12669;2020.
110.
Nishizawa T, Toyoshima O, Kondo R, Sekiba K, Tsuji Y, Ebinuma H, Suzuki H, Tanikawa
C, Matsuda K, Koike K. The simplified Kyoto classification score is consistent with the
ABC method of classification as a grading system for endoscopic gastritis. Journal of Clin
Biochem Nutr. 2020 in press.
111.
Hoang TT, Wheeldon TU, Bengtsson C, Phung DC, Sorberg M, Granstrom M. Enzymelinked immunosorbent assay for Helicobacter pylori needs adjustment for the population
investigated. J Clin Microbiol. 42(2):627-630;2004.
112.
Loffeld RJ, Werdmuller BF, Kusters JG, Kuipers EJ. IgG antibody titer against
Helicobacter pylori correlates with presence of cytotoxin associated gene A-positive H.
pylori strains. FEMS Immunol Med Microbiol. 28(2):139-141;2000.
113.
Flahou B, Haesebrouck F, Smet A, Yonezawa H, Osaki T, Kamiya S. Gastric and
Enterohepatic Non-Helicobacter pylori Helicobacters. Helicobacter. 18:66-72;2013.
114.
Fitzgerald RC, Hardwick R, Huntsman D, Carneiro F, Guilford P, Blair V, Chung DC,
Norton J, Ragunath K, Van Krieken JH, Dwerryhouse S, Caldas C. Hereditary diffuse
gastric cancer: updated consensus guidelines for clinical management and directions for
future research. Journal of Medical Genetics. 2010;47(7):436-444.
115.
Saeki N, Saito A, Choi IJ, Matsuo K, Ohnami S, Totsuka H, Chiku S, Kuchiba A, Lee YS,
Yoon KA, Kook MC, Park SR, Kim YW, Tanaka H, Tajima K, Hirose H, Tanioka F,
Matsuno Y, Sugimura H, Kato S, Nakamura T, Nishina T, Yasui W, Aoyagi K, Sasaki H,
Yanagihara K, Katai H, Shimoda T, Yoshida T, Nakamura Y, Hirohashi S, Sakamoto H. A
functional single nucleotide polymorphism in mucin 1, at chromosome 1q22, determines
susceptibility to diffuse-type gastric cancer. Gastroenterology. 140(3):892-902;2011.
116.
Hu N, Wang Z, Song X, Wei L, Kim BS, Freedman ND, Baek J, Burdette L, Chang J,
Chung C, Dawsey SM, Ding T, Gao YT, Giffen C, Han Y, Hong M, Huang J, Kim HS,
Koh WP, Liao LM, Mao YM, Qiao YL, Shu XO, Tan W, Wang C, Wu C, Wu MJ, Xiang
YB, Yeager M, Yook JH, Yuan JM, Zhang P, Zhao XK, Zheng W, Song K, Wang LD, Lin
D, Chanock SJ, Goldstein AM, Taylor PR, Abnet CC. Genome-wide association study of
gastric adenocarcinoma in Asia: a comparison of associations between cardia and noncardia tumours. Gut. 65(10):1611-1618;2016.
117.
Tanikawa C, Kamatani Y, Toyoshima O, Sakamoto H, Ito H, Takahashi A, Momozawa Y,
98
Hirata M, Fuse N, Takai-Igarashi T, Shimizu A, Sasaki M, Yamaji T, Sawada N, Iwasaki
M, Tsugane S, Naito M, Hishida A, Wakai K, Furusyo N, Murakami Y, Nakamura Y, Imoto
I, Inazawa J, Oze I, Sato N, Tanioka F, Sugimura H, Hirose H, Yoshida T, Matsuo K, Kubo
M, Matsuda K. Genome-wide association study identifies gastric cancer susceptibility loci
at 12q24.11-12 and 20q11.21. Cancer Sci. 109(12):4015-4024;2018.
118.
Matsuo K, Tajima K, Suzuki T, Kawase T, Watanabe M, Shitara ...
論文の公開元へ
